Roivant Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Roivant Sciences (ROIV).

Price Target Range — 12 Quarters

Analyst Consensus — 14 Analysts

13Buy

1Hold

Consensus RatingBuy# Analysts14Avg. Consensus PT$28Upside to Avg. PT-20.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
May 26, 2026	Guggenheim	Yatin Suneja	PT Raise	Buy	$30→$36
May 21, 2026	Citigroup	Samantha Semenkow	PT Raise	Buy	$35→$42
May 21, 2026	TD Cowen	Yaron Werber	PT Raise	Buy	$38→$41
May 21, 2026	HC Wainwright & Co.	Douglas Tsao	Maintained	Buy	$34
Apr 16, 2026	Piper Sandler	Yasmeen Rahimi	PT Raise	Overweight	$22→$40
Mar 4, 2026	HC Wainwright & Co.	Douglas Tsao	PT Raise	Buy	$33→$34
Feb 10, 2026	Citigroup	Samantha Semenkow	PT Raise	Buy	$26→$35
Feb 10, 2026	HC Wainwright & Co.	Douglas Tsao	PT Raise	Buy	$26→$33
Feb 9, 2026	Guggenheim	Yatin Suneja	PT Raise	Buy	$28→$30
Dec 15, 2025	Leerink Partners	David Risinger	PT Raise	Outperform	$29→$32
Dec 15, 2025	Goldman Sachs	Corinne Jenkins	PT Raise	Buy	$24→$33
Dec 12, 2025	HC Wainwright & Co.	Douglas Tsao	PT Raise	Buy	$23→$26
Nov 11, 2025	Citigroup	Samantha Semenkow	PT Raise	Buy	$25→$26
Oct 29, 2025	Citigroup	Samantha Semenkow	PT Raise	Buy	$16→$25
Sep 18, 2025	Goldman Sachs	Corinne Jenkins	PT Raise	Buy	$20→$24
Sep 18, 2025	Jefferies	Dennis Ding	PT Raise	Buy	$18→$20
Sep 18, 2025	JP Morgan	Brian Cheng	PT Raise	Overweight	$16→$20
Sep 18, 2025	Guggenheim	Yatin Suneja	PT Raise	Buy	$15→$21
Sep 18, 2025	Leerink Partners	David Risinger	PT Raise	Outperform	$18→$22
Sep 18, 2025	B of A Securities	Chi Fong	PT Raise	Neutral	$12→$17